New York Presbyterian Hospital (Cornell Campus) Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 374
• Acute Myeloid Leukemia Research 321
• Cancer Immunotherapy and Biomarkers 319
• Prostate Cancer Treatment and Research 290
• Bladder and Urothelial Cancer Treatments 245
• Chronic Lymphocytic Leukemia Research 226
• Myeloproliferative Neoplasms: Diagnosis and Treatment 191
• Multiple Myeloma Research and Treatments 178
• Hematopoietic Stem Cell Transplantation 171
• Lung Cancer Treatments and Mutations 157
• Immunotherapy and Immune Responses 155
• Cancer Cells and Metastasis 146

Most cited

1. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

   The New England journal of medicine · 2021 · 2,264 citations · Scott Tagawa

2. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.

   The New England journal of medicine · 2025 · 482 citations · Jedd D. Wolchok

3. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

   Blood · 2022 · 1,363 citations · John Leonard

4. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.

   Nature · 2023 · 1,126 citations · Jedd D. Wolchok

5. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.

   Lancet (London, England) · 2021 · 1,369 citations · Manish A Shah

6. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 981 citations · Jedd D. Wolchok